Treatment

HIV treatment is not only a life giver but a life saver.

published: February, 16, 2018 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Lifestyle, Treatment, Living with HIV, Guest Authors, Media, Opinion Pieces

From Uganda, Matovu William's first article as a regular contributor to PositiveLite.com discusses the many benefits of antiretroviral theraoy (ART).

HIV treatment is not only a life giver but a life saver.

According to UNAIDS, there were approximately 36.7 million people worldwide living with HIV/AIDS at the end of 2016. Of these, 2.1 million were children (<15 years old). As of July 2017, 20.9 million people living with HIV were accessing antiretroviral therapy (ART) globally, up from 15.8 million in June 2015, 7.5 million in 2010, and less than one million in 2000. HIV treatment known as Antiretroviral Therapy (ART) is medication which is given to HIV positive people to treat HIV but it do

Will de-simplification of HIV treatment become common in high-income countries?

published: February, 14, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Research, CATIE - HIV and Hep C Info Resource, Treatment, Media

From CATIE, Sean R. Hosein reports on a study exploring de-simplification as a cost-cutting measure.

Will de-simplification of HIV treatment become common in high-income countries?

- As more people start HIV treatment, researchers are exploring ways to cut costs - Single tablets can be replaced by a few pills comprising cheaper generic drugs - Alberta clinic projects $4.3 million saved by “de-simplifying” one treatment regimen Initiating and staying on HIV treatment (ART) results in most people having very low levels of HIV in their blood. Such low levels are commonly called undetectable and result in improved measures of health and projections of near-normal life

GNP+ signs on to U=U, gets warm reaction

published: February, 12, 2018 Written by // Bob Leahy - Publisher Categories // Social Media, African, Caribbean and Black, Activism, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Women, Health, International , Treatment, Media, Bob Leahy - Publisher

Fences were being mended as the Global Network of People Living with HIV (GNP+) announced last week its full endorsement of the “Undetectable equals Untransmittable” (U=U) campaign. Bob Leahy speaks to the principals.

GNP+ signs on to U=U, gets warm reaction

There have been many milestones in the two year history of U=U. In Canada, think of when CATIE came on board. Elsewhere, think of when U=U burst onto the world stage, quite literally, at IAS2017 in Paris. Or when the CDC embraced the science and said this, "people who take ART daily as prescribed and achieve and maintain an undetectable viral load have effectively no risk of sexually transmitting the virus to an HIV-negative partner." Or when leading U.S. scientist Anthony Fauci said this: "Fr

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

published: February, 08, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Research, Health, International , Treatment, Revolving Door, Guest Authors, Media

Scepticism among healthcare providers, patients and pharmacists about the safety and efficacy of generic medications is an important barrier. From AIDSmap, Keith Alcorn reports.

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

The potential savings from prescribing generic antiretrovirals predicted by economic models may be overstated and numerous barriers need to be overcome to bring down the cost of HIV treatment in higher-income countries, according to the findings of several recently-published analyses. Switching to cheaper generic versions of some antiretrovirals has been proposed as a means of freeing up money to treat more people with HIV in the United States and other higher-income countries where generics

Indigenizing research: the Wise Practices conference

published: February, 07, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, Health, Research, CATIE - HIV and Hep C Info Resource, Treatment, Media, Opinion Pieces

From CATIE Blog, Laurie Edmiston: "...while CAAN and the AHA Centre are trying to conduct community research while honouring Indigenous people’s processes, some of us are still trying to impose our own standards and measures on Indigenous communities."

Indigenizing research: the Wise Practices conference

This past year the Canadian Aboriginal AIDS Network (CAAN) held its annual gathering, on the theme of “transforming wholistic approaches to Indigenous health.” It’s a gathering of First Nations, Métis and Inuit people, combining a business meeting, a gathering of Aboriginal people with HIV/AIDS, and the ‘Wise Practices’ research conference. But more importantly, it is a gathering of colleagues who have become friends, clients who have become peers, people with HIV who have become

Disruptions in PrEP adherence provide insights into intimate partner violence

published: February, 06, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Women, Research, International , Revolving Door, Treatment, Guest Authors, Media

Study finds strong links between PrEP disruptions and intimate partner violence in Kenya and Uganda. Combined interventions could be key to improving adherence and linking victims to support services. From Avert.org, Francesca Harrington-Edmans reports.

Disruptions in PrEP adherence provide insights into intimate partner violence

Photo credit: istock/znm People who experience intimate partner violence (IPV) are more likely to miss doses of pre-exposure prophylaxis (PrEP), in Kenya and Uganda, according to new findings published in the Journal of Acquired Immune Deficiency Syndromes (JAIDS).                                                             The study, which recruited participants from four sites across Uganda and Kenya where PrEP was being offered

An epidemic of bullshit

published: February, 01, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Health, International , Treatment, Revolving Door, Guest Authors, Media

From Overland, guest author Daniel Reeders: "... messages on sexual health almost invariably focus on sex rather than health."

An epidemic of bullshit

Image credit: Reginald Mount, ‘The easy girlfriend’ (poster), Norwich: Her Majesty’s Stationery Office, 1943-44. This file comes from Wellcome Images, a website operated by Wellcome Trust, a global charitable foundation based in the United Kingdom. Refer to Wellcome blog post (archive). This article by Daniel Reeders previously appeared at Overland, here. Two or three times a year, there’ll be a major conference on sexual health, or a report released on how many new sexually tr

4 out of 5 gay, bi and men who have sex with men are aware of HIV prevention drug, PrEP

published: February, 01, 2018 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Research, Health, Sexual Health, Revolving Door, Treatment, Guest Authors, Media

Indigenous, Latino, bisexual and single men less likely to be aware of newly publicly-funded HIV prevention medication

4 out of 5 gay, bi and men who have sex with men are aware of HIV prevention drug, PrEP

(Vancouver, January 31, 2018) A new study shows most of gay, bi, men who have sex with men (MSM) and other MSM, are aware of PrEP (pre-exposure prophylaxis) - an HIV prevention drug recently made available at no charge to British Columbians at risk of HIV - according to the Momentum Health Study at the BC Centre for Excellence in HIV/AIDS. “Gay, bisexual, MSM and other MSM in Canada accounted for 56.8% of all new cases of HIV in Canada,” says research scientist, Nathan Lachowsky. “Incre

600 people a week turned away from oversubscribed sexual health clinics at one London NHS trust

published: January, 31, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Gay Men, Current Affairs, Newly Diagnosed, Treatment Guidelines -including when to start, Women, Health, Sexual Health, International , Revolving Door, Treatment, Guest Authors, Media

Closures have taken place across central London and remaining clinics across the capital are facing unmanageable demands. From the Evening Standard, Eleanor Rose reports.

600 people a week turned away from oversubscribed sexual health clinics at one London NHS trust

Testing: Digital services will allow people to carry out tests at home, but the rollout has been delayed. To read the complete story by Eleanor Rose, visit The Evening Standard, here. Up to 600 people per week are being turned away from oversubscribed sexual health clinics at one of London’s NHS trusts, an expert has warned. Dr Mark Lawton of the British Association of Sexual Health and HIV said the data showing hundreds of people are being turned away from clinic at Guy’s and St Tho

What will be the impact of PrEP in Ontario?

published: January, 30, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Research, Health, Treatment, Revolving Door, Guest Authors, Media

The breadth of data being collected is intended to help answer the wide range of questions about what “real-world” PrEP use looks like in the province. Jack Mohr of the Ontario PrEP Cohort Study has this report.

What will be the impact of PrEP in Ontario?

After years spent waiting, more widespread access to Pre-Exposure Prophylaxis (PrEP) in Ontario finally seems to be taking shape. Health Canada approval for generic forms of tenofovir disoproxil fumarate/emtricitabine (the drug combination used for PrEP) has drastically decreased out of pocket costs for PrEP.  This development, along with concerted lobbying from HIV activists, also led to the addition of PrEP to the Ontario Drug Benefit formulary in September 2017. While these changes don’t

Study links gut-homing protein levels with HIV infection risk, disease progression

published: January, 30, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Gay Men, Treatment Guidelines -including when to start, Women, Health, Research, International , Revolving Door, Treatment, Guest Authors, Media

From the National Institutes of Health: NIH clinical trial is testing antibody against the protein in people with HIV.

Study links gut-homing protein levels with HIV infection risk, disease progression

For the first time, scientists have shown a relationship between the proportion of key immune cells that display high levels of a gut-homing protein called alpha-4 beta-7 at the time of HIV infection and health outcomes. Previous research illustrated this relationship in monkeys infected with a simian form of HIV. The new study found that women who had more CD4+ T cells displaying high levels of alpha-4 beta-7 on their surface were more likely to become infected with HIV, and the virus damage

U=U laggards draw fire from the community

published: January, 29, 2018 Written by // Bob Leahy - Publisher Categories // African, Caribbean and Black, Activism, Social Media, Gay Men, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Women, Health, Treatment, Media, Opinion Pieces, Bob Leahy - Publisher

The Global U=U picture is good, but community activists are stepping up the heat on organizations which have been slow to embrace it. Today the spotlight is on Greater than AIDS, GNP+ and in Canada, the Ontario AIDS Network. Bob Leahy reports.

U=U laggards draw fire from the community

This article originallly appeared on January 16, 2018 If 2017 was a good year for many people living with HIV, it was for a simple, three character slogan that seemed to be everywhere. POZ.com, in awarding Undetectable equals Untransmittable, or U=U, the campaign of the year described it as “perhaps the most discussed and rapidly shared message to hit the HIV arena in years”. The Washington Post called it  “the campaign credited with beginning to change public perception of HIV trans

Women with HIV less likely to receive recommended treatments for gynaecologic cancers

published: January, 29, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Women, Health, International , Revolving Door, Treatment, Living with HIV, Guest Authors, Media

Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines.From AIDSmap, Michael Carter reports.

Women with HIV less likely to receive recommended treatments for gynaecologic cancers

The majority of HIV-positive women diagnosed with gynaecological cancer do not receive treatment recommended by cancer guidelines, according to research conducted in the United States and published in AIDS. Women whose care did not match guideline standards had poorer survival compared to women who received the recommended care. Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines. “To our knowledge, there is no case series de

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

published: January, 24, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Treatment Guidelines -including when to start, Newly Diagnosed, Research, Health, International , Revolving Door, Treatment, Guest Authors, Media

“Our results show that any detectable viral load between 51 and 999 copies per ml leads to poorer treatment outcomes than successful virological suppression of less than 50 copies per ml,” write the investigators. From AIDSmap, Keith Alcorn reports.

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

Low-level HIV viral load, above the limit of detection, is an important warning signal for future treatment failure and World Health Organization guidelines on spotting treatment failure need to be revised to encourage greater vigilance and swifter action by healthcare providers in lower- and middle-income settings, investigators report in The Lancet Infectious Diseases. The study, carried out by Annemarie Wensing and colleagues at the University of Utrecht in the Netherlands and University

PrEP’s social impact on the lives of some gay men in Toronto

published: January, 23, 2018 Written by // Guest Authors - Revolving Door Categories // Dating, African, Caribbean and Black, As Prevention , Gay Men, Youth, Treatment Guidelines -including when to start, Research, Health, CATIE - HIV and Hep C Info Resource, Sexual Health, Lifestyle, Treatment, Living with HIV

Researchers in Toronto conducted a PrEP demonstration project to assess its acceptability, use and effectiveness. From CATIE, Sean R. Hosein reports.

PrEP’s social impact on the lives of some gay men in Toronto

- Researchers interviewed early adopters of PrEP in Toronto about their experience. - Participants reported that their use of PrEP left them feeling “proud” and “liberated.” - Stigma and judgment related to PrEP also led some participants to conceal their use of it. PrEP (pre-exposure prophylaxis) involves taking two anti-HIV medicines in one pill, usually daily, to reduce the chance of getting HIV. PrEP is meant to be used in combination with other HIV prevention approaches, such a

[12 3 4 5  >>